amantadine has been researched along with raclopride in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Breimer, DD; Danysz, W; De Boer, AG; Hesselink, MB | 1 |
Carpinelli, A; Comi, G; Fazio, F; Gobbo, C; Messa, C; Moresco, RM; Rizzo, G; Volonté, MA | 1 |
Carpinelli, A; Fazio, F; Franceschi, M; Galli, L; Gobbo, C; Messa, C; Moresco, RM; Panzacchi, A; Rizzo, G; Volonte, MA | 1 |
1 trial(s) available for amantadine and raclopride
Article | Year |
---|---|
New perspectives on neurochemical effects of amantadine in the brain of parkinsonian patients: a PET - [(11)C]raclopride study.
Topics: Aged; Amantadine; Antiparkinson Agents; Brain Chemistry; Caudate Nucleus; Dopamine Antagonists; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neostriatum; Parkinson Disease; Putamen; Raclopride; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
3 other study(ies) available for amantadine and raclopride
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Adaptations of NMDA and dopamine D2, but not of muscarinic receptors following 14 days administration of uncompetitive NMDA receptor antagonists.
Topics: Amantadine; Animals; Brain; Caudate Nucleus; Dentate Gyrus; Dizocilpine Maleate; Entorhinal Cortex; Frontal Lobe; Hippocampus; Infusions, Parenteral; Kinetics; Male; Memantine; Nucleus Accumbens; Organ Specificity; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Salicylamides; Time Factors | 1999 |
A PET study with [11-C]raclopride in Parkinson's disease: preliminary results on the effect of amantadine on the dopaminergic system.
Topics: Aged; Amantadine; Binding, Competitive; Carbon Radioisotopes; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Presynaptic Terminals; Putamen; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Tomography, Emission-Computed | 2001 |